1. Home
  2. VERA vs ERO Comparison

VERA vs ERO Comparison

Compare VERA & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • ERO
  • Stock Information
  • Founded
  • VERA 2016
  • ERO 2016
  • Country
  • VERA United States
  • ERO Canada
  • Employees
  • VERA N/A
  • ERO N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • ERO
  • Sector
  • VERA Health Care
  • ERO
  • Exchange
  • VERA Nasdaq
  • ERO Nasdaq
  • Market Cap
  • VERA 2.0B
  • ERO 1.3B
  • IPO Year
  • VERA 2021
  • ERO N/A
  • Fundamental
  • Price
  • VERA $23.39
  • ERO $16.92
  • Analyst Decision
  • VERA Buy
  • ERO Strong Buy
  • Analyst Count
  • VERA 8
  • ERO 1
  • Target Price
  • VERA $64.63
  • ERO $19.00
  • AVG Volume (30 Days)
  • VERA 3.0M
  • ERO 507.1K
  • Earning Date
  • VERA 08-07-2025
  • ERO 07-31-2025
  • Dividend Yield
  • VERA N/A
  • ERO N/A
  • EPS Growth
  • VERA N/A
  • ERO N/A
  • EPS
  • VERA N/A
  • ERO 0.18
  • Revenue
  • VERA N/A
  • ERO $489,554,000.00
  • Revenue This Year
  • VERA N/A
  • ERO $73.94
  • Revenue Next Year
  • VERA N/A
  • ERO $20.16
  • P/E Ratio
  • VERA N/A
  • ERO $92.52
  • Revenue Growth
  • VERA N/A
  • ERO 13.24
  • 52 Week Low
  • VERA $18.53
  • ERO $9.30
  • 52 Week High
  • VERA $51.61
  • ERO $23.40
  • Technical
  • Relative Strength Index (RSI)
  • VERA 49.48
  • ERO 70.44
  • Support Level
  • VERA $20.40
  • ERO $15.71
  • Resistance Level
  • VERA $25.30
  • ERO $16.29
  • Average True Range (ATR)
  • VERA 1.31
  • ERO 0.56
  • MACD
  • VERA -0.02
  • ERO 0.03
  • Stochastic Oscillator
  • VERA 46.25
  • ERO 96.68

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

Share on Social Networks: